This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sun, Y. Articles by Schadendorf, D. Search for Related Content PubMed PubMed Citation Articles by Sun, Y. Articles by Schadendorf, D.

Expression of the Proteasome Activator PA28 Rescues the Presentation of a Cytotoxic T Lymphocyte Epitope on Melanoma Cells¹

Skin Cancer Unit of German Cancer Research Center, University of Heidelberg, Theodor Kutzer Ufer 1, 68135 Mannheim, Germany [Y. S., M. S., A. P., D. S.]; Institute of Biochemistry, Medical Faculty of Humboldt University, 10117 Berlin, Germany [A. J. A. M. S., K. J., S. K., P-M. K.]; and Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tübingen, Germany [A. K. N., M. S., S. S., H. S.]

The proteasome system represents a major source of HLA class I- presented peptides exposed to CTLs. Stimulation of cells with IFN- instantly induces the expression of the proteasome immunosubunits as well as the proteasome activator PA28. These proteins have been shown to optimize class I antigen presentation of several viral CTL epitopes; however, their contribution to tumor antigen processing remains poorly understood. Here, we analyzed the generation of an HLA-A*0201-presented epitope derived from the melanoma antigen tyrosinase-related protein 2 (TRP2). Melanoma cells that lacked the IFN--inducible proteasome activator PA28 and immunoproteasomes did not display the TRP2_360–368 epitope to specific CTLs. Our experiments demonstrate that epitope presentation correlated with the presence of PA28 and could be completely rescued by restoration of PA28 expression. In vitro digestion of TRP2 polypeptides with 20S proteasomes confirmed that PA28 is essential for epitope liberation. Thus, our experiments indicate that PA28 provides the threshold for CTL recognition of this epitope. Importantly, processing of a second TRP2-derived epitope, TRP2_288–296, was diminished in IFN--treated cells, even in the absence of immunoproteasome up-regulation. Therefore, the reported IFN--induced self-regulation of epitopes may not necessarily be a consequence of immunoproteasomes as suggested previously.

This article has been cited by other articles:

				K. Textoris-Taube, P. Henklein, S. Pollmann, T. Bergann, H. Weisshoff, U. Seifert, I. Drung, C. Mugge, A. Sijts, P.-M. Kloetzel, et al. The N-terminal Flanking Region of the TRP2360-368 Melanoma Antigen Determines Proteasome Activator PA28 Requirement for Epitope Liberation J. Biol. Chem., April 27, 2007; 282(17): 12749 - 12754. [Abstract] [Full Text] [PDF]

				I. Mlynarczuk-Bialy, H. Roeckmann, U. Kuckelkorn, B. Schmidt, S. Umbreen, J. Golab, A. Ludwig, C. Montag, L. Wiebusch, C. Hagemeier, et al. Combined effect of proteasome and calpain inhibition on Cisplatin-resistant human melanoma cells. Cancer Res., August 1, 2006; 66(15): 7598 - 7605. [Abstract] [Full Text] [PDF]

				Y. Sun, S. Stevanovic, M. Song, A. Schwantes, C. J. Kirkpatrick, D. Schadendorf, and K. Cichutek The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes Blood, February 15, 2006; 107(4): 1476 - 1483. [Abstract] [Full Text] [PDF]

				Y. Ito, E. Kondo, A. Demachi-Okamura, Y. Akatsuka, K. Tsujimura, M. Tanimoto, Y. Morishima, T. Takahashi, and K. Kuzushima Three Immunoproteasome-Associated Subunits Cooperatively Generate a Cytotoxic T-Lymphocyte Epitope of Epstein-Barr Virus LMP2A by Overcoming Specific Structures Resistant to Epitope Liberation J. Virol., January 15, 2006; 80(2): 883 - 890. [Abstract] [Full Text] [PDF]

				S. Heink, B. Fricke, D. Ludwig, P.-M. Kloetzel, and E. Kruger Tumor Cell Lines Expressing the Proteasome Subunit Isoform LMP7E1 Exhibit Immunoproteasome Deficiency Cancer Res., January 15, 2006; 66(2): 649 - 652. [Abstract] [Full Text] [PDF]

				S. Heink, D. Ludwig, P.-M. Kloetzel, and E. Kruger From The Cover: IFN-{gamma}-induced immune adaptation of the proteasome system is an accelerated and transient response PNAS, June 28, 2005; 102(26): 9241 - 9246. [Abstract] [Full Text] [PDF]

				A. A. Lugade, J. P. Moran, S. A. Gerber, R. C. Rose, J. G. Frelinger, and E. M. Lord Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor J. Immunol., June 15, 2005; 174(12): 7516 - 7523. [Abstract] [Full Text] [PDF]

				F. Ossendorp, N. Fu, M. Camps, F. Granucci, S. J. P. Gobin, P. J. van den Elsen, D. Schuurhuis, G. J. Adema, G. B. Lipford, T. Chiba, et al. Differential Expression Regulation of the {alpha} and {beta} Subunits of the PA28 Proteasome Activator in Mature Dendritic Cells J. Immunol., June 15, 2005; 174(12): 7815 - 7822. [Abstract] [Full Text] [PDF]

				L. F. Barton, H. A. Runnels, T. D. Schell, Y. Cho, R. Gibbons, S. S. Tevethia, G. S. Deepe Jr., and J. J. Monaco Immune Defects in 28-kDa Proteasome Activator {gamma}-Deficient Mice J. Immunol., March 15, 2004; 172(6): 3948 - 3954. [Abstract] [Full Text] [PDF]